AHMED, GULZAR,BOHNSTEDT, ADOLPH,BRESLIN, HENRY JOSEPH,BURKE, JASON,CURRY, MATTHEW A.,DIEBOLD, JAMES L.,DORSEY, BRUCE,DUGAN, BENJAMIN J.,FENG, DAMING,GINGRICH, DIANE E.,GUO, TAO,HO, KOC-KAN,LEARN, KEIT
申请号：
CA2669111
公开号：
CA2669111C
申请日:
2007.10.23
申请国别(地区):
CA
年份:
2016
代理人:
摘要：
The present invention provides a compound of formula I or II or a pharmaceutically acceptable salt form thereof, wherein R1, R2, R3, R4, R5, A1, A2, A3, A4, and A5, are as defined herein. The compounds of formula I or II have ALK and/or c-Met inhibitory activity, and may be used to treat proliferative disorders.
